More reads

• Insurers pitch new ways to pay for million-dollar therapies. (Wall Street Journal)
• Cancer drug approvals in the U.S. have surged over the past few decades. (STAT Plus)
• A turn for the worse for biotech stocks. (Wall Street Journal)